FDA inspection
Lundbeck Pharmaceuticals Italy S.p.A.: FDA inspection ending Sep 28, 2012
FDA inspection 801925 · No Action Indicated (NAI) · Padova
Key facts
| Inspection ID | 801925 |
|---|---|
| Firm | Lundbeck Pharmaceuticals Italy S.p.A. |
| FEI number | 3002808449 |
| Address | Zona Industriale Quarta Strada 2 |
| City | Padova |
| Country | Italy |
| Fiscal year | 2012 |
| Inspection end date | Sep 28, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data